ECE2013 Poster Presentations Adrenal cortex (64 abstracts)
Autonomous aldosterone secretion as a significant cause of arterial hypertension: the effectiveness of targeted therapy
Labrini Papanastasiou , Theodora Pappa , Stelios Fountoulakis , Panagiotis Tsounas , Athina Markou , Vaios Tsiavos , Marina Anastasakou , Chrisanthi Marakaki , Dimosthenis Malliopoulos , Theodora Kounadi & George Piaditis
Department of Endocrinology and Diabetes Center, ‘G Gennimatas’ General Hospital, Athens, Greece.
Introduction: The prevalence of autonomous aldosterone secretion (AAS) in hypertensive subjects varies due to the use of various suppression tests and cut-off values. Our aim was to evaluate the prevalence of AAS in hypertensive subjects and test the anti-hypertensive effect of targeted treatment of the renin angiotensin II aldosterone system (RAAS) in AAS subjects.
Description of methods/design: We investigated 336 hypertensive subjects with and without adrenal adenoma and 83 age- and sex- matched normotensive subjects, with normal adrenal glands on computerized tomography. Serum aldosterone (ALD) and active renin levels (REN) and the aldosterone/active renin (ALD/REN) ratio were measured before and after a modified fludrocortisone suppression test (FDST - fludrocortisone suppression test after dexamethasone administration). Normal cut-offs were obtained from the controls (ALD levels post-FDST 82 pmol/l and ALD/REN post-FDST 25 pmol/mIU per l).
Results: By applying the combination of serum ALD post-FDST levels and the ALD/REN post- FDST ratio, the prevalence of AAS in hypertensive subjects was 31.3%. We found positive correlations between systolic (SBP) and diastolic (DBP) blood pressure and serum ALD and the ALD/REN ratio before and post-FDST (P <0.001). After dividing in quintiles the ALD post-FDST levels of hypertensive subjects, the association of ALD post-FDST levels with SBP and DBP became statistically significant in the 4th (ALD levels >101 pmol/l) and 5th quintile (ALD levels >155 pmol/l) respectively. An inverse association between serum K+ and ALD post- FDST levels was shown, that became significant for K+ levels over 4 mEq/l.
Treatment targeting the RAAS with mineralocorticoid receptor antagonists or angiotensin II receptor blockers in 68 AAS subjects resulted in a marked decrease of SBP and DBP values (P<0.001).
Conclusions: Using this methodology for detection of AAS an increased prevalence of AAS was found in hypertensive subjects. Targeted treatment of AAS subjects adequately controlled their blood pressure.
Article tools
My recent searches
My recently viewed abstracts
Authors
Endocrine Abstracts
ISSN 1470-3947 (print) | ISSN 1479-6848 (online)
© Bioscientifica 2024 |
Privacy policy |
Cookie settings
BiosciAbstracts
Bioscientifica Abstracts is the gateway to a series of products that provide a permanent, citable record of abstracts for biomedical and life science conferences.
Find out more